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Abstract Several MHC class II restricted, CD4’ human T cell clones from three donors were induced with soluble matrix protein of influenza virus. 
The epitopes recognized by these clones were mapped using a complete set of overlapping 15-mer peptides ynthesized with the newly developed SPOT 
method which allows the simple simultaneous ynthesis of numerous peptides on cellulose membranes. Fine analysis of two clones by truncation 
of the stimulatory peptide by single subsequent amino acids from either the NH*- or the COOH-terminus revealed the minimal stimulatory 
determinants of two DQ dependent T cell epitopes. 
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1. Introduction 
T cells only recognize antigens in a processed form as short 
peptides bound to molecules of the MHC [1,2]. For character- 
isation of a particular T cell response it is therefore necessary 
to map the individual epitopes recognized by the T cell clones, 
usually by scanning the protein sequence with a series of over- 
lapping synthetic peptides. This requires a preparation of a 
large number of peptides amongst which only a few are stimu- 
latory. To this end it would be desirable to have a method which 
allows the fast, simultaneous ynthesis of multiple peptides with 
a minimal requirement of cost and labour. Recently, the synthe- 
sis of peptides on cellulose membranes - SPOT synthesis - has 
been introduced by one of the authors which fulfills all of the 
criteria mentioned above. This represents an easy and flexible 
method for the rapid and economic preparation of large num- 
bers of peptides on a small scale [3]. To date, this method has 
primarily been applied to B-cell epitope mapping - the determi- 
nation of antibody binding specificity to arrays of membrane 
bound peptides. Here we demonstrate that SPOT synthesis is 
equally convenient to prepare solution phase peptides and that 
the quantities and qualities of peptides are suitable for such 
delicate assay systems as T cell stimulation. Using a series of 
soluble peptides prepared by the SPOT method, we studied the 
fine specificity of two DQ restricted CD4’ T cell clones specific 
for the matrix protein of influenza virus. 
2. Materials and methods 
2.1. Preparation of Influenza M protein 
Influenza A/FPV/Rostock 34 (H7Nl) virus was grown in alantois 
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fluid of day 12 chicken embryos. Matrix protein was purified from 
concentrated virus suspension by lysis with 2% SDS at 37°C for 2 h 
followed by gel filtration on AcA44 (Serva, Heidelberg, Germany). 
Purity was assessed by immunoblotting using polyclonal rabbit anti- 
total virus proteins (kindly supplied by Dr. H.D. Klenk, Marburg). 
2.2. Induction of human T cell clones 
Peripheral blood lymphocytes of two donors were stimulated with 
various dilutions of matrix protein starting with 10 &ml. Cloning, 
maintenance and proliferation assays were performed as described [4]. 
2.3. Peptide synthesis by the SPOT method 
Assembly of the peptides shown in Figs. 2 and 3 was carried out 
utilizing Fmocchemistry essentially as described [3]. Appropriate cellu- 
lose membranes derivatized with spots of Boc-Lys-Pro-dipeptide an- 
chors were used to allow a final cleavage of peptides in aqueous olution 
[S]. The solubilized peptide thus remains modified C-terminally by a 
Lys-Prodiketopiperazine. Chr-1 chromatography paper (Whatman, 
Maidstone, UK) was derivatized first with N”-Fmoc-proline to give a 
substitution of 0.25 pmol per cm*. After cleavage of Fmoc with 20% 
piperidine in DMF, 1 ~1 aliquots of a 0.3 M solution of N”-Boc, 
N”-Fmoc-lysine HOBf ester were applied at intervals of 1 cm. Residual 
free proline residues were blocked by acetylation and the Fmoc group 
at the lysine removed with piperidine. The resulting spots had a diam- 
eter of 0.7 cm and carried about 25 nmol of dipeptide anchors as 
determined by amino group titration [2,3]. Peptides were assembled by 
spotting 1.5 ~1 aliquots of 0.3 M solutions of Fmoc-amino acid pen- 
tafluorophenyl esters per elongation cycle. Special side chain protection 
was Arg(Pmc), Asn(Trt), Gln(Trt), His(Trt), and Trp(Boc). 
After completion of chain assembly, peptides were N-terminally ace- 
tylated and side chain protecting groups removed by treatment with 
50% TFA, 3% triisobutylsilane in DCM for 2 h. The membranes were 
then washed successively with DCM (4 times for 10 min), methanol/ 
water (1: 1, v/v) containing 0.1% hydrochloric acid (3 times for 20 min) 
and 1 M acetic acid in water (3 times for 20 min), and then vacuum dried 
overnight. Individual spots were punched out with a DotPunch from 
Inotech Biosystems (purchased from Bibby Dunn Labortechnik 
GmbH, Asbach, Germany) and placed into 2 ml Eppendorf tubes. 
Peptides were eluted by overnight incubation at 37°C with 0.5 ml of 
0.1 M triethylammonium acetate (pH 7.5) containing 20% ethanol. 
These solutions were transferred to a second tube and the paper spots 
eluted again with 0.5 ml of the same buffer. The combined eluates were 
dried in a vacuum centrifuge, dissolved in 0.5 ml PBS and stored at 
- 2o”c. 
HPLC-separations were carried out on an analytical reversed-phase 
silica gel column (Nucleosil 30&7Cl8, 4x250 mm, Macherey-Nagel, 
Diiren, Germany) with gradients of acetonitrile/O.l% TFA in water/ 
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0.1% TFA at a flow rate of 1 mllmin. Mass spectra were recorded on 
a Kratos MS 50RF instrument with a high field magnet (mass range 
ca. 10,000 at 8 kV) and a Kratos FAB source using a beam of neutral 
xenon atoms at 8-9 kV and thioglycerol as matrix. Peak fractions from 
HPLC separations containing 5 to 10 pug peptide were evaporated to
dryness, dissolved in3 ~1 DMSO and aliquots thereof were injected into 
the thioglycerol matrix. 
3. Results 
3.1. Synthesis, e&ion and mass analysis of soluble peptides 
Spot synthesis allows a flexible choice of format with respect 
to number and scale of individual peptide syntheses [3]. Here 
we set the final yield to be in the lo-50 nmol range. This 
resulted in an array of 10 x 7 spots arranged of 1 cm apart on 
a 12 x 9 cm Chrl chromatography paper sheet, each spot carry- 
ing about 25 nmol of dipeptide anchor. The elegant concept of 
an orthogonal peptide-support anchor developed by Bray et al. 
[5] was adapted to spot synthesis. It allows the final deprotec- 
tion and removal of contaminating chemicals while the peptide 
remains attached to the support. This is followed by the direct 
release of the peptide into an aqueous buffer of choice. 
Spots of Boc-Lys-Pro anchor were generated on the cellulose 
membrane, onto which the peptides were assembled via the 
e-amino function of the lysine residue. Completed peptides 
were released from individual punched out spots by 
diketopiperazine formation at neutral pH. The diketo- 
piperazine moiety remains C-terminally bound to the peptide. 
Valerio et al. [6] have demonstrated that this modification does 
not significantly impede biological activity in T-cell stimulation 
assays. For peptide synthesis, conventional Fmoc chemistry 
was utilized and peptides up to a length of 20 amino acid 
residues were successfully assembled as proven by HPLC and 
mass spectrometry analyses (Fig. 1). This material was used in 
the functional T cell assays. 
3.2. T-Cell epitope mapping by overlapping peptides 
For characterization of the T cell clones which had been 
established by stimulating PBL with purified influenza matrix 
protein, a series of peptides was synthesized (Fig. 2), to reduce 
the chances of destruction of the antigenic determinant. A 
length of 15 AA was chosen. For the same reason, an overlap 
in sequence of 10 AA was used beween neighbouring peptides. 
The eluted peptides (ca. 20 nmol) were dissolved in 500 ~1 PBS, 
and 10 ~1 were mixed with T cell clones together with either 
irradiated PBLs or EBV transformed B cell lines as antigen 
presenting cells. For most T cell clones it was possible to assign 
one or two overlapping stimulatory peptides (Fig. 2). This indi- 
cates that the peptides are of suitable quality, as already sug- 
gested by the analyses using a mass spectrometer, and in addi- 
tion that they are free of toxic substances. 
3.3. Fine specijicity of two DQ restricted T cell clones 
Clones from two donors of different haplotypes were found 
which displayed reactivity to the peptides of the carboxy termi- 
nus of the influenza M protein. The exact epitope for two such 
clones was established by a second set of peptides. Based on a 
20-mer consisting of the complete sequence of peptides 47 and 
48, variants were synthesized which displayed successive single 
AA truncations from either the NH,- or COOH-terminus. As 
shown in Fig. 3, the two T cell clones studied recognized two 
similar but not identical peptides. The restriction element of 
both clones was determined by blocking the proliferation with 
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Fig. 1. Analysis of an eluted 20-mer peptide synthesized on a cellulose 
matrix. Upper panel: HPLC trace of crude Ac-Val-Leu-Ser-Ile-Ile-Pro- 
Ser-Gly-Pro-Leu-Lys-Ala-Glu-Ile-Ala-DKP (Lys-Pro) which is peptide 
No. 3 from Fig. 2 (% B = concentration of acetonitrile, A,,, = absorb- 
ance at 214 nm). Lower panel: FAB mass spectrum of the prominent 
peak from upper panel showing the expected correct mass. 
MHC class II specific antibodies. Monoclonal antibodies 
against either DR, DP or DQ (L243, B7.21 or SPVL3, respec- 
tively) were added to the proliferation assays using the 20-mer 
peptide as antigen. DQ could be clearly identified as the restric- 
tion element of both clones (data not shown). One donor (DR6 
homozygous) had been typed positive for DQwl, the second 
donor (DR5 homozygous) is most likely DQw3 due to genetic 
disequilibrium of the DR5 haplotype in the Caucasian popula- 
tion [7]. The exact alleles of the DQ molecules remain to be 
determined. 
4. Discussion 
Many class II dependent antigens have been investigated in 
the human system. Of the antigenic determinants characterized, 
most have been found to be presented by DR molecules and 
only a few determinants have been described which depend on 
DQ molecules [&lo]. The finding that T cell clones isolated 
from different donors for reactivity against the M protein of 
influenza virus were mainly restricted to DQ molecules (clones 
GP 3.2, ALF 3.7 and data not shown) was therefore surprising. 
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T cell clone 
DRS donor: GP 2.1 
GP 2.3 
GP 3.2 
DR6 donor: AL 1.3 
AL 1.4 
AL 2.1 
AL 3.7 
AL 4.4 
unknown : SA 3.2 
SA 3.5 
SA 3.8 
Peptide 
19/20 30/31 43 
47/48149 
47148149 
48149 
41 
41 
48149 
48149 
42143 
43144 
34135 
Fig. 2. Display of the simultaneously synthesized peptides used to scan the matrix protein of influenza virus for T cell epitopes. The insert shows 
the reactivity of various T cell clones from three donors of whom two had been typed for DR. 
During an influenza infection T cells most likely encounter 
antigen in the respiratory tract. The high frequency of DQ 
restricted T cell clones might indicate that antigen presenting 
cells at this site display a quantitatively different composition 
of class II molecule isotypes than antigen-presenting cells in the 
blood stream. A higher expression of DP and DQ on antigen 
presenting cells in gut-associated tissue has been observed 
(Thorsby, personal communication). 
The minimal stimulatory peptides of T cell clones derived 
from the two donors of different haplotypes are overlapping in 
sequence - AYQKRMGVQMQR for DQwl and LENLQA- 
YQKR for DQw3 - and both require basic AA (Arg) at the 
COOH terminus. They differ, however, in the required length 
(12 AA and 10 AA, respectively). This might reflect a better fit 
of the shorter peptide to its particular binding site on the class 
II molecule, but also could reflect differences in the recognition 
by the T cell receptor. Since data on other peptides which bind 
to identical DQ alleles are not yet available, it is difficult to 
speculate as to which residues are essential for binding to the 
DQ molecules. 
Through sequencing of peptides eluted from selected MHC 
class I molecules it was possible to define anchor residues which 
are essential for binding of a peptide to a particular class I 
molecule [ 111. Using this knowledge it is now possible to predict 
potential stimulatory peptides of a given antigen with a high 
probability [ 121. Since anchor residues for peptides binding to 
class II molecules seem to be more degenerate, prediction of 
epitopes of class II restricted T cell clones is still rather difficult, 
requiring scanning of whole antigens or fragments thereof by 
overlapping peptides. A suitable method of peptide synthesis 
which can be performed with minimal cost would therefore be 
desirable for investigators interested in T cell receptor-antigen 
interaction. We could show here that the SPOT method of 
simultaneous peptide synthesis, which has successfully been 
used for epitope mapping of monoclonal antibodies [3], could 
also be adapted to efficient screening of T cell epitopes. HPLC 
and mass spectroscopy revealed that even peptides up to a 
length of 20 AA could be synthesized with excellent yields. The 
peptides were stimulatory in functional T cell assays even at 
high concentrations, indicating that the peptides were not con- 
taminated with toxic substances remaining from the synthesis 
or deprotection. 
The SPOT synthesis therefore represents a convenient 
method to simultaneously synthesize peptides for biological 
assays without the requirement of expensive apparatus. In ad- 
dition the synthesis has recently been semi-automated to allow 
an even larger number of peptides to be synthesized simultane- 
ously. This should be of great benefit not only for epitope 
screening, but also for other applications such as screening 
for peptide antagonist which specifically interfere with T cell 
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Fig. 3. Fine mapping of two DQ restricted T cell clones by proliferation assay. 
responses [13], the latter for possible use in the specific treat- 
ment of immunological disorders. 
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